manilatimes

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company” or "Polyrizon”), a development stage biotech company specializing in the development of innovative ...

New Cap Releases Xingpu Large Model: Deep Customization for the Education Sector, Accelerating AI Empowerment

Characteristics and Advantages of the Xingpu Large Model The Xingpu large model was created by a high-quality team of experts, gathering talent from top institutions such as Oxford University, ...
Finanznachrichten

Polyrizon Ltd.: Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...